文献速递流行病学与生物统计医学教育与科研方法

健康志愿者对I期临床试验风险的认知:混合方法研究

Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
PubMed 文献 · PLoS Med · 2018-11-20

该研究基于美国178名健康志愿者的半结构化访谈,采用混合方法分析其对I期临床试验整体风险与个人受害风险的认知差异。多数参与者认为试验整体风险为中高或极高(118/178),但多数仍感觉个人安全(97/178)。首次参与、少数族裔及西班牙裔参与者更倾向于认为整体风险高,但个人风险感知无差异。

要点

  • 健康志愿者常区分试验整体风险与个人风险,整体视为高风险但自感安全。
  • 首次参与、少数族裔及西班牙裔志愿者更易高估整体风险。
  • 个人风险感知在不同临床 trial 历史与人口学特征间无显著差异。

核心结论

  • 健康志愿者普遍知晓并反思I期试验风险,整体风险与个人风险认知存在分离,可解释其持续入组行为。

研究设计与样本

  • 混合方法研究,对178名参与过多种I期试验的美国健康志愿者进行半结构化访谈的定性定量分析。

主要发现

  • 参与者集体经验涉及1948项I期试验(均值10.9,中位数5)。
  • 118/178认为I期试验整体风险为中、高或极高,但97/178感觉个人安全。
  • 首次参与、少数族裔及西班牙裔参与者更倾向认为整体风险高(分别Jonckheere-Terpstra -2.433, p=0.015;Fisher精确检验 p=0.016;Fisher精确检验 p=0.008)。
  • 上述群体在个人受害风险感知上无差异(分别卡方3.578, p=0.059;卡方0.845, p=0.358;卡方1.667, p=0.197)。

临床怎么用

  • 知情同意与风险沟通应区分试验整体风险与个人风险,针对首次参与及少数族裔志愿者加强沟通。

局限性

  • 将深度访谈数据定量汇总需研究团队解读非标准化风险叙述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is limited research on healthy volunteers' perceptions of the risks of Phase I clinical trials. In order to contribute empirically to long-standing ethical concerns about healthy volunteers' involvement in drug development, it is crucial to assess how these participants understand trial risks. The objectives of this study were to investigate (1) participants' views of the overall risks of Phase I trials, (2) their views of the risk of personally being harmed in a trial, and (3) how risk perceptions vary across participants' clinical trial history and sociodemographic characteristics. METHODS AND FINDINGS: We qualitatively and quantitatively analyzed semi-structured interviews conducted with 178 healthy volunteers who had participated in a diverse range of Phase I trials in the United States. Participants had collective experience in a reported 1,948 Phase I trials (mean = 10.9; median = 5), and they were interviewed as part of a longitudinal study of healthy volunteers' risk perceptions, their trial enrollment decisions, and their routine health behaviors. Participants' qualitative responses were coded, analyzed, and subsequently quantified in order to assess correlations between their risk perceptions and demographics, such as their race/ethnicity, gender, age, educational attainment, employment status, and household income. We found that healthy volunteers often viewed the overall risks of Phase I trials differently than their own personal risk of harm. The majority of our participants thought that Phase I trials were medium, high, or extremely high risk (118 of 178), but most nonetheless felt that they were personally safe from harm (97 of 178). We also found that healthy volunteers in their first year of clinical trial participation, racial and ethnic minority participants, and Hispanic participants tended to view the overall trial risks as high (respectively, Jonckheere-Terpstra, -2.433, p = 0.015; Fisher exact test, p = 0.016; Fisher exact test, p = 0.008), but these groups did not differ in regard to their perceptions of personal risk of harm (respectively, chi-squared, 3.578, p = 0.059; chi-squared, 0.845, p = 0.358; chi-squared, 1.667, p = 0.197). The main limitation of our study comes from quantitatively aggregating data from in-depth interviews, which required the research team to interpret participants' nonstandardized risk narratives. CONCLUSIONS: Our study demonstrates that healthy volunteers are generally aware of and reflective about Phase I trial risks. The discrepancy in healthy volunteers' views of overall and personal risk sheds light on why healthy volunteers might continue to enroll in clinical trials, even when they view trials on the whole as risky.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Fisher JA, McManus L, Cottingham MD, et al. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study. PLoS Med. 2018. PMID: 30457992. doi:10.1371/journal.pmed.1002698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。